The United States Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, MD this week announced an intent to issue a sole source award to the Research Foundation of the State University of New York (SUNY RF), on behalf of Upstate Medical Center, Syracuse, NY.
The required services are to utilize proteomics to characterize host immune responses by identifying distinct protein signatures in blood samples collected from individuals following acute dengue virus (DENV) infection or vaccination with a tetravalent live attenuated DENV vaccine.
Dengue infection is a leading cause of illness and death in the tropics and subtropics. As many as 100 million people are infected yearly. Dengue is caused by any one of four related viruses transmitted by mosquitoes. There are not yet any vaccines to prevent infection with DENV and the most effective protective measures are those that avoid mosquito bites. (CDC Dengue Map)
Dengue has emerged as a worldwide problem only since the 1950s. Although dengue rarely occurs in the continental United States, it is endemic in Puerto Rico, and in many popular tourist destinations in Latin America and Southeast Asia.
Further details are available under Solicitation Number: W81XWH12T0489
